These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29241779)

  • 1. Interrater reliability for histopathologic diagnosis of keratinocyte carcinomas.
    Leader NF; Means AD; Robinson-Bostom L; Telang GH; Wilkel CS; Weinstock MA;
    J Am Acad Dermatol; 2018 Jan; 78(1):185-187. PubMed ID: 29241779
    [No Abstract]   [Full Text] [Related]  

  • 2. Keratinocyte alterations in skin tumour development.
    Leigh IM; Purkis PE; Markey A; Collins P; Neill S; Proby C; Glover M; Lane EB
    Recent Results Cancer Res; 1993; 128():179-91. PubMed ID: 7689238
    [No Abstract]   [Full Text] [Related]  

  • 3. Cohort studies (and skin cancer) never come alone.
    Verkouteren JAC; van der Leest RJT; Nijsten T
    J Invest Dermatol; 2015 Mar; 135(3):649-651. PubMed ID: 25666670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing Risk of Death in Kaplan-Meier Curves When Analyzing Subsequent Keratinocyte Cancer.
    Verkouteren JA; Nijsten T; Hollestein LM
    JAMA Dermatol; 2016 Apr; 152(4):493-4. PubMed ID: 27074363
    [No Abstract]   [Full Text] [Related]  

  • 5. Competing Risk of Death in Kaplan-Meier Curves When Analyzing Subsequent Keratinocyte Cancer-Reply.
    Wehner MR; Linos E; Boscardin WJ; Chren MM
    JAMA Dermatol; 2016 Apr; 152(4):494-5. PubMed ID: 27074364
    [No Abstract]   [Full Text] [Related]  

  • 6. Azathioprine and risk of multiple keratinocyte cancers.
    Cho HG; Kuo KY; Xiao K; Batra P; Li S; Tang JY; Sarin KY
    J Am Acad Dermatol; 2018 Jan; 78(1):27-28.e1. PubMed ID: 28989107
    [No Abstract]   [Full Text] [Related]  

  • 7. Reliability of the histopathologic diagnosis of keratinocyte carcinomas.
    Jagdeo J; Weinstock MA; Piepkorn M; Bingham SF;
    J Am Acad Dermatol; 2007 Aug; 57(2):279-84. PubMed ID: 17482716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithms for ascertaining keratinocyte carcinomas using health insurance claims and prescription records.
    Zhang T; Lee TK; Lui H; Kunimoto B; Han C; Zhou Y; Kalia S
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e275-e276. PubMed ID: 30762901
    [No Abstract]   [Full Text] [Related]  

  • 9. A Model to Predict the Risk of Keratinocyte Carcinomas.
    Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM;
    J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How likely is another nonmelanoma skin cancer?: better informing patients and clinicians.
    Wu PA; Stern RS
    JAMA Dermatol; 2015 Apr; 151(4):369-70. PubMed ID: 25587795
    [No Abstract]   [Full Text] [Related]  

  • 11. FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness.
    Matas-Nadal C; Gatius S; Ribes-Santolaria M; Guasch-Vallés M; Gomez Arbones X; Casanova JM; Aguayo-Ortiz RS; Garí E
    Arch Dermatol Res; 2024 Jun; 316(7):342. PubMed ID: 38847933
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of actinic keratosis count in patients with multiple keratinocyte carcinomas: A cross-sectional study.
    Siegel JA; Luber AJ; Weinstock MA;
    J Am Acad Dermatol; 2017 Feb; 76(2):346-349. PubMed ID: 28088997
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Lee KC; Weinstock MA;
    J Am Acad Dermatol; 2010 Dec; 63(6):1107-9. PubMed ID: 21093671
    [No Abstract]   [Full Text] [Related]  

  • 14. Basal cell and squamous cell carcinomas. Clinico-histological features.
    Annessi G; Baliva G
    Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.
    Siegel JA; Chren MM; Weinstock MA;
    J Am Acad Dermatol; 2016 Sep; 75(3):639-642. PubMed ID: 27543222
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data.
    Abbas M; Kalia S
    J Cutan Med Surg; 2016; 20(2):166-75. PubMed ID: 26458408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in usage of the terms keratinocyte carcinoma and nonmelanoma skin cancer in the medical literature.
    Beatson M; Misitzis A; Lew RA; Weinstock MA
    Br J Dermatol; 2019 Dec; 181(6):1308-1309. PubMed ID: 31175660
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-melanoma skin cancer: an overindulged circumlocution articulating keratinocytic cancer.
    Ruocco V; Ruocco E; Brunetti G; Schwartz RA
    Int J Dermatol; 2014 Mar; 53(3):e228-9. PubMed ID: 23565967
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in identifying predictors of subsequent keratinocyte carcinoma development: an institutional cohort analysis.
    Thomas S; Taylor M; Sharma D; Plampton K; High R; Wysong A; Sutton A
    Arch Dermatol Res; 2024 Jun; 316(7):410. PubMed ID: 38878204
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidental granular parakeratotic cornification in carcinomas.
    Resnik KS; DiLeonardo M
    Am J Dermatopathol; 2007 Jun; 29(3):264-9. PubMed ID: 17519624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.